NCPDP Annual Conference: Track Sessions

Tuesday, May 7, 2024

9:30 a.m. – 10:30 a.m.
Pooja Babbrah, MBA
PBM Practice Lead
Point-of-Care Partners
Tricia Lee Rolle Pharm.D., MS, PhD
Senior Advisor, Office of the National Coordinator
U.S. Dept. of Health and Human Services
Kim Boyd
Senior Consultant and Regulatory Resource Center Lead
Point-of-Care Partners
11:00 a.m. – 12:00 p.m.
Anna Dover, Pharm.D., BCPS
Director, Product Management
FDB (First Databank, Inc.)
Julie Suko, Pharm.D.
Vice President, Editorial Content
FDB (First Databank, Inc.)
Jason Reed, Pharm.D
Senior Director, Product Management
FDB Vela
Edward D. Millikan, Pharm.D.
Senior Informatics Pharmacist
Office of Surveillance and Epidemiology (OSE), Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Jeff Deitch
Chief Executive Officer
Infowerks
Kelee Petzelt
Consultant
Point-of-Care Partners

Wednesday, May 8, 2024

11:15 a.m. – 11:45 p.m.
Mason Ingram
Director, Payer Policy
Premier Inc.

Laura D. Pone, JD
Associate, Health Care Alignment and Organization Practice
Polsinelli PC

12:00 p.m. – 12:30 p.m.
Kim Boyd
President | Principal Consultant
Boyd Consulting Group, LLC

Kristol Chism, R.Ph.
Director, Industry Relations
Optum Insight

Miranda Rochol
Senior Vice President for Provider Solutions
Prescryptive Health, Inc.

Miranda Reich , POPM
Senior Product Manager
Inovalon

Samantha Pitts, MD, MPH
Assistant Professor
Division of General Internal Medicine, Johns Hopkins Medicine

Mark Gunnels
Vice President and Principal Architect, Product Engineering
Tabula Rasa HealthCare

Candida Ruesga
Attorney
The Phoenix Law Group, PLC

Pharmacists and Pharmacy Technicians can earn Continuing Pharmacy Education (CPE) hours from the ACPE for up to 11 of the 12 concurrent educational track sessions. Complete CPE Details for NCPDP’s 2024 Annual Conference coming soon!

 

How Pharmacists Could Confirm if a Patient’s Genes are a Good Fit for a Drug

  • Tuesday, May 7, 2024
  • 11:00 a.m. – 12:00 p.m.

Pharmacogenomics (PGx) presents an enormous opportunity in personalized medicine to maximize clinical benefit and minimize safety risk. At the point of prescription fulfillment, however, pharmacists have little insight into the potential risk or efficacy of a drug based on their patients’ genetic profile, which could result in suboptimal care. This presentation delivered by clinical and drug-knowledge experts describes how pharmacist workflows could be seamlessly updated with pharmacogenomics information to keep patients safe and improve prescribing decisions.

Track Session Speakers

  • Anna Dover, Pharm.D., BCPS
  • Director, Product Management
  • FDB (First Databank, Inc.)
  • Jason Reed, Pharm.D
  • Senior Director, Product Management
  • FDB Vela
  • Julie Suko, Pharm.D.
  • Vice President, Editorial Content
  • FDB (First Databank, Inc.)
NCPDP-Elite Partner

Covermymeds logo             FDB

NCPDP’s Elite Partner Program establishes the highest level of sustained support for the valuable work of NCPDP in advancing patient safety and interoperability.

Need More Info?

We would love to hear from you. Send us a message with your comment or question and a member of our staff will contact you shortly.

       
Stay Connected